Wrongful Death

October 21, 2009

Trial Set in Wrongful Death of Wal-Mart Slip and Fall

A trial date has been set in the case against Wal-Mart in the death of a Chadron, Neb., woman.

David Lehman sued the corporation shortly after his wife, Julie, died after falling in the Chadron store. The case, filed in Dawes County District Court was removed to the U.S. District Court, which has scheduled a trial for Feb. 16.

Julie Lehman was in Wal-Mart July 21 with her son, Steffan, 17, when she slipped on a wet floor in the automotive cleaning products aisle on her way to the restroom. Julie received her initial diagnosis and treatment at the Chadron Community Hospital before being flown to Rapid City Regional to have a massive blood clot in her brain surgically removed. Julie never woke up after surgery and died July 27.

October 20, 2009

Metrolink Pays Out $30 M in 2005 Crash Settlements

by Dr. Shezad Malik

After years of foot dragging, Metrolink has spent $30 million to settle most of the lawsuits arising from the 2005 Glendale train crash that killed 11 and injured about 180, according to plaintiffs’ attorneys.

Among those settlements are two injury cases, one for $5 million and the other for $3.8 million, and two wrongful death cases in which the heirs will receive $3.5 million for each claim. One of those cases involves payments to the family of a sheriff’s deputy killed in the crash.

October 19, 2009

Hospital Settles After Patient’s Fall in Operating Room

by Dr. Shezad Malik

The family of an 86-year-old Boston woman who died after she fell from an operating table following hip surgery has settled a wrongful death lawsuit with Boston Medical Center.

The family’s lawyer, Meyer, said the hospital agreed to pay $900,000.

Meyer said the case exposed gaps in operating room procedures and hopefully will prevent future tragedies.

October 19, 2009

New Rules Opens Toxic Injury Health Claims to Agent Orange

by Dr. Shezad Malik

Under rules to be proposed this week, the Department of Veterans Affairs plans to add Parkinson’s disease, ischemic heart disease and hairy-cell leukemia to the growing list of illnesses presumed to have been caused by Agent Orange, the toxic defoliant used widely in Vietnam.

The proposal will make it substantially easier for thousands of veterans to claim that those ailments were the direct result of their service in Vietnam, thereby for them to receive monthly disability checks and health care services from the department.

The new policy will apply to some 2.1 million veterans who set foot in Vietnam during the war, including those who came after the military stopped using Agent Orange in 1970. It will not apply to sailors on deep-water ships, though the department plans to study the effects of Agent Orange on the Navy.

October 18, 2009

Dallas Texas Yaz Lawsuits and Side Effects

by Dr. Shezad Malik

The United States Judicial Panel on Multidistrict Litigation issued its order on October 1, 2009, establishing MDL No. 2100 for individual lawsuits filed by women who have been injured as a result of their ingestion of Yasmin, Yaz and Ocella oral contraceptive products. All of the cases pending in federal courts will be transferred to the Southern District of Illinois. The initial transfer order includes 32 cases that have been filed by patients in California, Georgia, New York, Ohio, Pennsylvania, Puerto Rico, and Wisconsin.

All of the cases involve allegations that the popular birth control pills containing the new progestin drospirenone increase the risk of serious life-threatening health problems, such as heart attacks, strokes, pulmonary embolisms, deep vein thrombosis, gallbladder disease and sudden death from Yaz or Yasmin.

October 18, 2009

Statute of Limitations for Texas Yaz Product Liability Lawsuits

by Dr. Shezad Malik

Yaz, manufactured by Bayer Healthcare Pharmaceuticals, Inc., is a combination birth control pill containing drospirenone and ethinyl estradiol. Yaz is marketed not only as a contraceptive pill, but as a proven treatment for premenstrual dysphoric disorder (PMDD), a condition with severe emotional and physical premenstrual symptoms. Yaz also is marketed as an effective treatment for moderate acne.

The YAZ birth control pill, manufactured and marketed by Bayer Pharmaceuticals has been linked to a number of serious, life-threatening side effects.

There is a limited period of time in which to bring a Texas Yaz lawsuit. This time period is referred to as a “statute of limitations”. If Yaz lawsuits are not filed before the statutory deadline you may lose the right to bring a claim for compensation.

A statute of limitations is a law that limits the amount of time a person has to file a lawsuit. There are several factors that affect the statutory deadline for filing your Yaz lawsuit. Some of these factors include:

The state where the injury occurred, the type of injury, the state where the lawsuit is filed, the age of the person bringing the lawsuit, whether the claim is a wrongful death lawsuit.

October 16, 2009

Yaz / Yasmin MDL Consolidation Update

by Dr. Shezad Malik

A panel of judges ordered that all federal lawsuits over problems with Yaz and Yasmin birth control pills will be consolidated into an MDL, or multidistrict litigation, for pretrial proceedings in the Southern District of Illinois.

This is not a Yaz / Yasmin class action. Each Yaz lawsuit or Yasmin lawsuit will remain an individual claim and if a settlement is not agreed upon during pretrial litigation, each plaintiff will still have a jury will determine the amount of damages they are entitled to in their case.

Read the JPML Order here.

MDL No. 2100 — IN RE: Yasmin and Yaz (Drospirenone) Marketing and Sales Practices and Products Liability Litigation — Assigned To Southern District of Illinois.

October 15, 2009

Deaths Linked To Yaz and Yasmin Birth Control Pill

by Dr. Shezad Malik

It was August, 2008, when 24-year-old Tanya Hayes began to experience breathlessness and what her family described as a “nasty, hard cough.” Tanya ignored the symptoms until one afternoon when she collapsed in a car park in her hometown of Melbourne, Australia. Five hours later, she was pronounced dead of a pulmonary embolism.

According to the head of the emergency room that treated Ms. Hayes, her death was the result of “blood clotting caused by factors related to taking the oral contraceptive pill.”
What her family did not discover until later is that the fine print on the package of pills she was taking, known as Yasmin, lists “breathlessness” as a “very rare . . . very serious side effect.”

October 15, 2009

Settlement For Philadelphia Apartment-Fire Litigation

by Dr. Shezad Malik

Less than 14 months after a devastating apartment blaze along the Conshohocken riverfront set back one of the nation’s most successful revivals of an aging town, a $36.3 million settlement has been reached to end all fire-related litigation.

Of that, $27 million will go toward rebuilding the two destroyed Riverwalk apartment buildings, which housed 189 units. The remainder will be shared among the displaced tenants, with amounts depending on individual losses.

October 13, 2009

Glaxo Ordered to Pay $2.5 M for Paxil Birth Defect Lawsuit

by Dr. Shezad Malik

GlaxoSmithKline Plc must pay $2.5 M over claims that its Paxil antidepressant caused birth defects, a Pennsylvania jury concluded in the first of 600 such cases to come to trial.

Jurors in state court in Philadelphia deliberated about seven hours over two days before finding Glaxo failed to properly warn doctors and pregnant users of Paxil’s risk. The panel awarded $2.5 million in compensatory damages to the family of Lyam Kilker. The 3-year-old was born with heart defects his mother blamed on the drug.